🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
30 Servings
Fat/Fatty Acid Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
5 mg (2% DV)

Other Ingredients

Fish Oil Softgel natural Citrus flavor Antioxidant Blend

Label Claims — Verification

Nutrient
All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: 2 softgels daily with a meal.

⚠️ Warnings & Precautions

Store in a cool, dry place out of reach of children.

🧪 Formulation Notes

Barlean's Fresh Catch Ultra EPA-DHA Fish Oil

1,300 mg of Omega-3s in just two softgels

From wild caught fish

Free of mercury and other heavy metals Non-GMO, Gluten Free, no PCBs

Pharmaceutical Grade Ultra Purified

1,300 mg Omega-3

Additional Information

From our family to yours Barbara Barlean David Barlean Bruce Barlean

Learn more about a pathway to a better life: barleans.com

FreshTech Patented Softgel Technology

Barlean's estd 1989

Keep bottle tightly closed. Store in a cool, dry place out of reach of children.

Product of U.S.A.

Product Details

UPC / SKU 7 05875 61006 3
DSLD Entry Date 2020-03-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Barlean's
DSLD ID 215877
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →